Myndtec

MyndTec is dedicated to developing innovative neurotechnology products that enhance the lives of individuals with neurological disorders, chronic pain, and central nervous system injuries, including stroke and spinal cord injuries. With over a decade of experience in FDA and Health Canada-cleared products, we are developing AI-driven technologies to leverage this expertise, aiming to improve patient care, streamline decision-making, and enhance healthcare efficiency. Our solutions address both invasive and non-invasive therapeutic needs for a growing global patient population. What our new technologies bring: AI-Enhanced Treatments: We are developing AI-driven technologies to optimize treatments for chronic pain and movement disorders. Better Patient Outcomes: We focus on improving treatment success rates to enhance the quality of life for patients. Cost Savings: By improving patient outcomes and streamlining treatments, we aim to reduce healthcare costs. Note: This new technology is currently undergoing clinical testing. Its safety and effectiveness have not yet been established or approved by the FDA or Health Canada.